Drug information for DOPAMINE HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine INTL MEDICATION 18014
INJECTABLE; INJECTION 160MG/100ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine HOSPIRA 18132
INJECTABLE; INJECTION 40MG/ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine HOSPIRA   "
INJECTABLE; INJECTION 80MG/100ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine HOSPIRA   "
INJECTABLE; INJECTION 80MG/ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine HOSPIRA   "
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine WARNER CHILCOTT 18138
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine BAXTER HLTHCARE 18398
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine BAXTER HLTHCARE   "
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine LYPHOMED 18549
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 18656
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine SMITH AND NEPHEW 70011
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABRAXIS PHARM 70012
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABRAXIS PHARM 70013
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine SMITH AND NEPHEW 70046
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine SMITH AND NEPHEW 70047
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABRAXIS PHARM 70058
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABRAXIS PHARM 70059
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70087
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70089
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70090
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70091
INJECTABLE; INJECTION 160MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70092
INJECTABLE; INJECTION 160MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70093
INJECTABLE; INJECTION 160MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ASTRAZENECA 70094
INJECTABLE; INJECTION 160MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABRAXIS PHARM 70364
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine WARNER CHILCOTT 70558
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine WARNER CHILCOTT 70559
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABBOTT 70656
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine ABBOTT 70657
INJECTABLE; INJECTION 40MG/ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine LUITPOLD 70799
INJECTABLE; INJECTION 80MG/ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine LUITPOLD 70820
INJECTABLE; INJECTION 160MG/ML Prescription AP (Reference Drug) DOPAMINE HYDROCHLORIDE Dopamine LUITPOLD 70826
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine TEVA PARENTERAL 72999
INJECTABLE; INJECTION 80MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine TEVA PARENTERAL 73000
INJECTABLE; INJECTION 40MG/ML Discontinued   DOPAMINE HYDROCHLORIDE Dopamine HOSPIRA 74403

Drug Adverse Effects information for DOPAMINE HYDROCHLORIDE

Role code Indications Reaction # Reports
SS ASCITES TOXIC EPIDERMAL NECROLYSIS 1
SS BONE MARROW TRANSPLANT ANGIOEDEMA 3
SS BONE MARROW TRANSPLANT ASCITES 3
SS BONE MARROW TRANSPLANT OBSTRUCTIVE AIRWAYS DISORDER 3
SS BONE MARROW TRANSPLANT STEVENS-JOHNSON SYNDROME 3
SS CARDIAC FAILURE HYPERNATRAEMIA 4
SS CARDIAC FAILURE THIRST 4
SS CARDIAC FAILURE TOXIC EPIDERMAL NECROLYSIS 1
SS ESSENTIAL HYPERTENSION TOXIC EPIDERMAL NECROLYSIS 3
SS FLATULENCE TOXIC EPIDERMAL NECROLYSIS 2
SS FLUID RETENTION HYPERNATRAEMIA 2
SS FLUID RETENTION THIRST 2
SS PRODUCT USED FOR UNKNOWN INDICATION ANGIOEDEMA 28
SS PRODUCT USED FOR UNKNOWN INDICATION ASCITES 28
SS PRODUCT USED FOR UNKNOWN INDICATION OBSTRUCTIVE AIRWAYS DISORDER 28
SS PRODUCT USED FOR UNKNOWN INDICATION STEVENS-JOHNSON SYNDROME 28
SS PROPHYLAXIS TOXIC EPIDERMAL NECROLYSIS 7
SS RENAL FAILURE TOXIC EPIDERMAL NECROLYSIS 1
SS SEDATION TOXIC EPIDERMAL NECROLYSIS 1
SS SURGERY TOXIC EPIDERMAL NECROLYSIS 1
SS UNEVALUABLE EVENT ANGIOEDEMA 5
SS UNEVALUABLE EVENT ASCITES 5
SS UNEVALUABLE EVENT OBSTRUCTIVE AIRWAYS DISORDER 5
SS UNEVALUABLE EVENT STEVENS-JOHNSON SYNDROME 5
C ACUTE MYELOID LEUKAEMIA ACUTE MYELOID LEUKAEMIA 2
C ACUTE MYELOID LEUKAEMIA CLOSTRIDIUM DIFFICILE COLITIS 2
C ACUTE MYELOID LEUKAEMIA PYREXIA 2
C ACUTE MYELOID LEUKAEMIA SEPSIS 2
C ACUTE MYELOID LEUKAEMIA URINARY TRACT INFECTION PSEUDOMONAL 2
C ACUTE MYELOID LEUKAEMIA VENOOCCLUSIVE LIVER DISEASE 2
C ANTIBIOTIC PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C ANTIBIOTIC PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 2
C ANTIBIOTIC PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C ANTIBIOTIC PROPHYLAXIS HAEMATURIA 1
C ANTIBIOTIC PROPHYLAXIS INTERSTITIAL LUNG DISEASE 2
C ANTIBIOTIC PROPHYLAXIS SEPSIS 2
C ANTIBIOTIC PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 1
C ANTIBIOTIC PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 2
C ANTICOAGULANT THERAPY RENAL FAILURE ACUTE 1
C ANTIFUNGAL PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C ANTIFUNGAL PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 6
C ANTIFUNGAL PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8
C ANTIFUNGAL PROPHYLAXIS HAEMATURIA 3
C ANTIFUNGAL PROPHYLAXIS INTERSTITIAL LUNG DISEASE 6
C ANTIFUNGAL PROPHYLAXIS SEPSIS 6
C ANTIFUNGAL PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 3
C ANTIFUNGAL PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 6
C ANTIVIRAL PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C ANTIVIRAL PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 6
C ANTIVIRAL PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6
C ANTIVIRAL PROPHYLAXIS HAEMATURIA 3
C ANTIVIRAL PROPHYLAXIS INTERSTITIAL LUNG DISEASE 6
C ANTIVIRAL PROPHYLAXIS SEPSIS 6
C ANTIVIRAL PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 3
C ANTIVIRAL PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 6
C APLASTIC ANAEMIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6
C BLOOD ANTIDIURETIC HORMONE ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C BLOOD ANTIDIURETIC HORMONE CYTOMEGALOVIRUS TEST POSITIVE 2
C BLOOD ANTIDIURETIC HORMONE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C BLOOD ANTIDIURETIC HORMONE HAEMATURIA 1
C BLOOD ANTIDIURETIC HORMONE INTERSTITIAL LUNG DISEASE 2
C BLOOD ANTIDIURETIC HORMONE SEPSIS 2
C BLOOD ANTIDIURETIC HORMONE THROMBOTIC MICROANGIOPATHY 1
C BLOOD ANTIDIURETIC HORMONE VIRAL HAEMORRHAGIC CYSTITIS 2
C BLOOD PRESSURE DECREASED ANAEMIA 1
C BLOOD PRESSURE DECREASED DISSEMINATED INTRAVASCULAR COAGULATION 1
C BLOOD PRESSURE DECREASED NEUTROPHIL COUNT DECREASED 1
C BLOOD PRESSURE DECREASED RENAL FAILURE 1
C BLOOD PRESSURE DECREASED SYSTEMIC CANDIDA 1
C BONE MARROW CONDITIONING REGIMEN ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4
C BONE MARROW CONDITIONING REGIMEN ACUTE MYELOID LEUKAEMIA 3
C BONE MARROW CONDITIONING REGIMEN BRONCHOPULMONARY ASPERGILLOSIS 9
C BONE MARROW CONDITIONING REGIMEN CLOSTRIDIUM DIFFICILE COLITIS 3
C BONE MARROW CONDITIONING REGIMEN CYTOMEGALOVIRUS TEST POSITIVE 5
C BONE MARROW CONDITIONING REGIMEN EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 14
C BONE MARROW CONDITIONING REGIMEN FUNGAL INFECTION 9
C BONE MARROW CONDITIONING REGIMEN HAEMATURIA 4
C BONE MARROW CONDITIONING REGIMEN HISTIOCYTOSIS HAEMATOPHAGIC 9
C BONE MARROW CONDITIONING REGIMEN INTERSTITIAL LUNG DISEASE 5
C BONE MARROW CONDITIONING REGIMEN MULTI-ORGAN FAILURE 9
C BONE MARROW CONDITIONING REGIMEN PYREXIA 3
C BONE MARROW CONDITIONING REGIMEN SEPSIS 8
C BONE MARROW CONDITIONING REGIMEN THROMBOTIC MICROANGIOPATHY 4
C BONE MARROW CONDITIONING REGIMEN URINARY TRACT INFECTION PSEUDOMONAL 3
C BONE MARROW CONDITIONING REGIMEN VENOOCCLUSIVE LIVER DISEASE 1
C BONE MARROW CONDITIONING REGIMEN VIRAL HAEMORRHAGIC CYSTITIS 5
C BONE MARROW FAILURE BRONCHOPULMONARY ASPERGILLOSIS 9
C BONE MARROW FAILURE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9
C BONE MARROW FAILURE FUNGAL INFECTION 9
C BONE MARROW FAILURE HISTIOCYTOSIS HAEMATOPHAGIC 9
C BONE MARROW FAILURE MULTI-ORGAN FAILURE 9
C BRONCHITIS ANAEMIA 1
C BRONCHITIS DISSEMINATED INTRAVASCULAR COAGULATION 1
C BRONCHITIS NEUTROPHIL COUNT DECREASED 1
C BRONCHITIS RENAL FAILURE 1
C BRONCHITIS SYSTEMIC CANDIDA 1
C CANCER PAIN ANAEMIA 1
C CANCER PAIN DISSEMINATED INTRAVASCULAR COAGULATION 1
C CANCER PAIN NEUTROPHIL COUNT DECREASED 1
C CANCER PAIN RENAL FAILURE 1
C CANCER PAIN SYSTEMIC CANDIDA 1
C CARDIAC FAILURE BLOOD CREATINE INCREASED 1
C CARDIAC FAILURE BLOOD UREA INCREASED 1
C CARDIAC FAILURE DEPRESSED LEVEL OF CONSCIOUSNESS 1
C CARDIAC FAILURE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C CARDIAC FAILURE HYPERNATRAEMIA 1
C CARDIAC FAILURE HYPOVOLAEMIA 1
C CARDIAC FAILURE CONGESTIVE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C CARDIAC TAMPONADE PERICARDIAL HAEMORRHAGE 1
C COLON CANCER ANAEMIA 2
C COLON CANCER DISSEMINATED INTRAVASCULAR COAGULATION 2
C COLON CANCER NEUTROPHIL COUNT DECREASED 2
C COLON CANCER RENAL FAILURE 2
C COLON CANCER SYSTEMIC CANDIDA 2
C COLONY STIMULATING FACTOR THERAPY ACUTE MYELOID LEUKAEMIA 1
C COLONY STIMULATING FACTOR THERAPY CLOSTRIDIUM DIFFICILE COLITIS 1
C COLONY STIMULATING FACTOR THERAPY PYREXIA 1
C COLONY STIMULATING FACTOR THERAPY SEPSIS 1
C COLONY STIMULATING FACTOR THERAPY URINARY TRACT INFECTION PSEUDOMONAL 1
C CONVULSION PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2
C CONVULSION PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 4
C CONVULSION PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C CONVULSION PROPHYLAXIS HAEMATURIA 2
C CONVULSION PROPHYLAXIS INTERSTITIAL LUNG DISEASE 4
C CONVULSION PROPHYLAXIS SEPSIS 4
C CONVULSION PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 2
C CONVULSION PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 4
C CYTOMEGALOVIRUS INFECTION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C DIABETES MELLITUS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C DIARRHOEA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C DISSEMINATED INTRAVASCULAR COAGULATION ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C DISSEMINATED INTRAVASCULAR COAGULATION CYTOMEGALOVIRUS TEST POSITIVE 2
C DISSEMINATED INTRAVASCULAR COAGULATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C DISSEMINATED INTRAVASCULAR COAGULATION HAEMATURIA 1
C DISSEMINATED INTRAVASCULAR COAGULATION INTERSTITIAL LUNG DISEASE 2
C DISSEMINATED INTRAVASCULAR COAGULATION SEPSIS 2
C DISSEMINATED INTRAVASCULAR COAGULATION THROMBOTIC MICROANGIOPATHY 1
C DISSEMINATED INTRAVASCULAR COAGULATION VIRAL HAEMORRHAGIC CYSTITIS 2
C EMERGENCY CARE ACUTE MYELOID LEUKAEMIA 9
C EMERGENCY CARE CLOSTRIDIUM DIFFICILE COLITIS 9
C EMERGENCY CARE PYREXIA 9
C EMERGENCY CARE SEPSIS 9
C EMERGENCY CARE URINARY TRACT INFECTION PSEUDOMONAL 9
C GRAFT VERSUS HOST DISEASE ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C GRAFT VERSUS HOST DISEASE CYTOMEGALOVIRUS TEST POSITIVE 2
C GRAFT VERSUS HOST DISEASE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C GRAFT VERSUS HOST DISEASE HAEMATURIA 1
C GRAFT VERSUS HOST DISEASE INTERSTITIAL LUNG DISEASE 2
C GRAFT VERSUS HOST DISEASE SEPSIS 2
C GRAFT VERSUS HOST DISEASE THROMBOTIC MICROANGIOPATHY 1
C GRAFT VERSUS HOST DISEASE VIRAL HAEMORRHAGIC CYSTITIS 2
C HYPERLIPIDAEMIA ANAEMIA 1
C HYPERLIPIDAEMIA DISSEMINATED INTRAVASCULAR COAGULATION 1
C HYPERLIPIDAEMIA NEUTROPHIL COUNT DECREASED 1
C HYPERLIPIDAEMIA RENAL FAILURE 1
C HYPERLIPIDAEMIA SYSTEMIC CANDIDA 1
C HYPERTENSION ANAEMIA 2
C HYPERTENSION DISSEMINATED INTRAVASCULAR COAGULATION 2
C HYPERTENSION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C HYPERTENSION NEUTROPHIL COUNT DECREASED 2
C HYPERTENSION RENAL FAILURE 2
C HYPERTENSION SYSTEMIC CANDIDA 2
C HYPERVENTILATION ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2
C HYPERVENTILATION CYTOMEGALOVIRUS TEST POSITIVE 4
C HYPERVENTILATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C HYPERVENTILATION HAEMATURIA 2
C HYPERVENTILATION INTERSTITIAL LUNG DISEASE 4
C HYPERVENTILATION SEPSIS 4
C HYPERVENTILATION THROMBOTIC MICROANGIOPATHY 2
C HYPERVENTILATION VIRAL HAEMORRHAGIC CYSTITIS 4
C HYPOPHAGIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 10
C INFECTION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C INFECTION PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C INFECTION PROPHYLAXIS ACUTE MYELOID LEUKAEMIA 3
C INFECTION PROPHYLAXIS CLOSTRIDIUM DIFFICILE COLITIS 3
C INFECTION PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 6
C INFECTION PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6
C INFECTION PROPHYLAXIS HAEMATURIA 3
C INFECTION PROPHYLAXIS INTERSTITIAL LUNG DISEASE 6
C INFECTION PROPHYLAXIS PYREXIA 3
C INFECTION PROPHYLAXIS SEPSIS 9
C INFECTION PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 3
C INFECTION PROPHYLAXIS URINARY TRACT INFECTION PSEUDOMONAL 3
C INFECTION PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 6
C INSOMNIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5
C INTRACRANIAL HYPOTENSION ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C INTRACRANIAL HYPOTENSION CYTOMEGALOVIRUS TEST POSITIVE 2
C INTRACRANIAL HYPOTENSION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C INTRACRANIAL HYPOTENSION HAEMATURIA 1
C INTRACRANIAL HYPOTENSION INTERSTITIAL LUNG DISEASE 2
C INTRACRANIAL HYPOTENSION SEPSIS 2
C INTRACRANIAL HYPOTENSION THROMBOTIC MICROANGIOPATHY 1
C INTRACRANIAL HYPOTENSION VIRAL HAEMORRHAGIC CYSTITIS 2
C METASTATIC GASTRIC CANCER ABDOMINAL ADHESIONS 1
C METASTATIC GASTRIC CANCER ABDOMINAL PAIN 1
C METASTATIC GASTRIC CANCER ANAEMIA 1
C METASTATIC GASTRIC CANCER DEHYDRATION 1
C METASTATIC GASTRIC CANCER DEPRESSED LEVEL OF CONSCIOUSNESS 1
C METASTATIC GASTRIC CANCER DIARRHOEA 1
C METASTATIC GASTRIC CANCER FATIGUE 1
C METASTATIC GASTRIC CANCER GASTROINTESTINAL PERFORATION 1
C METASTATIC GASTRIC CANCER ILEUS 1
C METASTATIC GASTRIC CANCER INTERNAL HERNIA 1
C METASTATIC GASTRIC CANCER INTESTINAL OBSTRUCTION 1
C METASTATIC GASTRIC CANCER NAUSEA 1
C METASTATIC GASTRIC CANCER OEDEMA PERIPHERAL 1
C METASTATIC GASTRIC CANCER PYREXIA 1
C METASTATIC GASTRIC CANCER STOMATITIS 1
C METASTATIC GASTRIC CANCER VOMITING 1
C MULTIPLE MYELOMA SEPSIS 2
C MULTIPLE MYELOMA WHITE BLOOD CELL COUNT DECREASED 2
C NEUROLEPTIC MALIGNANT SYNDROME HEPATITIS FULMINANT 1
C OEDEMA ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C OEDEMA CYTOMEGALOVIRUS TEST POSITIVE 2
C OEDEMA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C OEDEMA HAEMATURIA 1
C OEDEMA INTERSTITIAL LUNG DISEASE 2
C OEDEMA SEPSIS 2
C OEDEMA THROMBOTIC MICROANGIOPATHY 1
C OEDEMA VIRAL HAEMORRHAGIC CYSTITIS 2
C ORAL CANDIDIASIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C ORAL CANDIDIASIS CYTOMEGALOVIRUS TEST POSITIVE 2
C ORAL CANDIDIASIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C ORAL CANDIDIASIS HAEMATURIA 1
C ORAL CANDIDIASIS INTERSTITIAL LUNG DISEASE 2
C ORAL CANDIDIASIS SEPSIS 2
C ORAL CANDIDIASIS THROMBOTIC MICROANGIOPATHY 1
C ORAL CANDIDIASIS VIRAL HAEMORRHAGIC CYSTITIS 2
C OROPHARYNGEAL PAIN EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C OSTEOPOROSIS PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C PLATELET COUNT DECREASED BRONCHOPULMONARY ASPERGILLOSIS 9
C PLATELET COUNT DECREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9
C PLATELET COUNT DECREASED FUNGAL INFECTION 9
C PLATELET COUNT DECREASED HISTIOCYTOSIS HAEMATOPHAGIC 9
C PLATELET COUNT DECREASED MULTI-ORGAN FAILURE 9
C PLATELET COUNT DECREASED RENAL FAILURE ACUTE 1
C PNEUMONIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C PNEUMONIA FUNGAL ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C PNEUMONIA FUNGAL CYTOMEGALOVIRUS TEST POSITIVE 2
C PNEUMONIA FUNGAL EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C PNEUMONIA FUNGAL HAEMATURIA 1
C PNEUMONIA FUNGAL INTERSTITIAL LUNG DISEASE 2
C PNEUMONIA FUNGAL SEPSIS 2
C PNEUMONIA FUNGAL THROMBOTIC MICROANGIOPATHY 1
C PNEUMONIA FUNGAL VIRAL HAEMORRHAGIC CYSTITIS 2
C PREMEDICATION ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C PREMEDICATION ACUTE MYELOID LEUKAEMIA 2
C PREMEDICATION ANAEMIA 2
C PREMEDICATION BRONCHOPULMONARY ASPERGILLOSIS 18
C PREMEDICATION CLOSTRIDIUM DIFFICILE COLITIS 2
C PREMEDICATION CYTOMEGALOVIRUS TEST POSITIVE 2
C PREMEDICATION DISSEMINATED INTRAVASCULAR COAGULATION 2
C PREMEDICATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 20
C PREMEDICATION FUNGAL INFECTION 18
C PREMEDICATION HAEMATURIA 1
C PREMEDICATION HISTIOCYTOSIS HAEMATOPHAGIC 18
C PREMEDICATION INTERSTITIAL LUNG DISEASE 2
C PREMEDICATION MULTI-ORGAN FAILURE 18
C PREMEDICATION NEUTROPHIL COUNT DECREASED 2
C PREMEDICATION PYREXIA 2
C PREMEDICATION RENAL FAILURE 2
C PREMEDICATION SEPSIS 4
C PREMEDICATION SYSTEMIC CANDIDA 2
C PREMEDICATION THROMBOTIC MICROANGIOPATHY 1
C PREMEDICATION URINARY TRACT INFECTION PSEUDOMONAL 2
C PREMEDICATION VIRAL HAEMORRHAGIC CYSTITIS 2
C PRODUCT USED FOR UNKNOWN INDICATION ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C PRODUCT USED FOR UNKNOWN INDICATION BRONCHOPULMONARY ASPERGILLOSIS 261
C PRODUCT USED FOR UNKNOWN INDICATION CYTOMEGALOVIRUS TEST POSITIVE 2
C PRODUCT USED FOR UNKNOWN INDICATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 263
C PRODUCT USED FOR UNKNOWN INDICATION FUNGAL INFECTION 261
C PRODUCT USED FOR UNKNOWN INDICATION HAEMATURIA 1
C PRODUCT USED FOR UNKNOWN INDICATION HISTIOCYTOSIS HAEMATOPHAGIC 261
C PRODUCT USED FOR UNKNOWN INDICATION INTERSTITIAL LUNG DISEASE 2
C PRODUCT USED FOR UNKNOWN INDICATION MULTI-ORGAN FAILURE 261
C PRODUCT USED FOR UNKNOWN INDICATION SEPSIS 2
C PRODUCT USED FOR UNKNOWN INDICATION THROMBOTIC MICROANGIOPATHY 1
C PRODUCT USED FOR UNKNOWN INDICATION VENOOCCLUSIVE LIVER DISEASE 38
C PRODUCT USED FOR UNKNOWN INDICATION VIRAL HAEMORRHAGIC CYSTITIS 2
C PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C PROPHYLAXIS ACUTE MYELOID LEUKAEMIA 1
C PROPHYLAXIS BRONCHOPULMONARY ASPERGILLOSIS 72
C PROPHYLAXIS CLOSTRIDIUM DIFFICILE COLITIS 1
C PROPHYLAXIS CYTOMEGALOVIRUS TEST POSITIVE 6
C PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 84
C PROPHYLAXIS FUNGAL INFECTION 72
C PROPHYLAXIS HAEMATURIA 3
C PROPHYLAXIS HISTIOCYTOSIS HAEMATOPHAGIC 72
C PROPHYLAXIS INTERSTITIAL LUNG DISEASE 6
C PROPHYLAXIS MULTI-ORGAN FAILURE 72
C PROPHYLAXIS PERICARDIAL HAEMORRHAGE 3
C PROPHYLAXIS PYREXIA 1
C PROPHYLAXIS SEPSIS 10
C PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 3
C PROPHYLAXIS URINARY TRACT INFECTION PSEUDOMONAL 1
C PROPHYLAXIS VIRAL HAEMORRHAGIC CYSTITIS 6
C PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 3
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER CYTOMEGALOVIRUS TEST POSITIVE 6
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HAEMATURIA 3
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER INTERSTITIAL LUNG DISEASE 6
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER SEPSIS 6
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER THROMBOTIC MICROANGIOPATHY 3
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER VIRAL HAEMORRHAGIC CYSTITIS 6
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ACUTE MYELOID LEUKAEMIA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE CLOSTRIDIUM DIFFICILE COLITIS 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE CYTOMEGALOVIRUS TEST POSITIVE 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE HAEMATURIA 3
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE INTERSTITIAL LUNG DISEASE 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PYREXIA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE SEPSIS 7
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE THROMBOTIC MICROANGIOPATHY 3
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE URINARY TRACT INFECTION PSEUDOMONAL 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE VIRAL HAEMORRHAGIC CYSTITIS 5
C PROSTATE CANCER RENAL FAILURE ACUTE 2
C PYREXIA ANAEMIA 5
C PYREXIA DISSEMINATED INTRAVASCULAR COAGULATION 5
C PYREXIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C PYREXIA NEUTROPHIL COUNT DECREASED 5
C PYREXIA RENAL FAILURE 5
C PYREXIA SYSTEMIC CANDIDA 5
C RED BLOOD CELL COUNT DECREASED BRONCHOPULMONARY ASPERGILLOSIS 9
C RED BLOOD CELL COUNT DECREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9
C RED BLOOD CELL COUNT DECREASED FUNGAL INFECTION 9
C RED BLOOD CELL COUNT DECREASED HISTIOCYTOSIS HAEMATOPHAGIC 9
C RED BLOOD CELL COUNT DECREASED MULTI-ORGAN FAILURE 9
C SEDATION BLOOD PRESSURE DECREASED 1
C SEDATION BRADYCARDIA 1
C SEDATION CARDIAC ARREST 1
C SEDATION MELAENA 1
C SEPSIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C SUPPLEMENTATION THERAPY ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1
C SUPPLEMENTATION THERAPY CYTOMEGALOVIRUS TEST POSITIVE 2
C SUPPLEMENTATION THERAPY EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C SUPPLEMENTATION THERAPY HAEMATURIA 1
C SUPPLEMENTATION THERAPY INTERSTITIAL LUNG DISEASE 2
C SUPPLEMENTATION THERAPY SEPSIS 2
C SUPPLEMENTATION THERAPY THROMBOTIC MICROANGIOPATHY 1
C SUPPLEMENTATION THERAPY VIRAL HAEMORRHAGIC CYSTITIS 2
C SYSTEMIC MYCOSIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C TACHYCARDIA ANAEMIA 1
C TACHYCARDIA DISSEMINATED INTRAVASCULAR COAGULATION 1
C TACHYCARDIA NEUTROPHIL COUNT DECREASED 1
C TACHYCARDIA RENAL FAILURE 1
C TACHYCARDIA SYSTEMIC CANDIDA 1
C WHITE BLOOD CELL COUNT DECREASED RENAL FAILURE ACUTE 1
C WHITE BLOOD CELL COUNT INCREASED ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2
C WHITE BLOOD CELL COUNT INCREASED CYTOMEGALOVIRUS TEST POSITIVE 4
C WHITE BLOOD CELL COUNT INCREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C WHITE BLOOD CELL COUNT INCREASED HAEMATURIA 2
C WHITE BLOOD CELL COUNT INCREASED INTERSTITIAL LUNG DISEASE 4
C WHITE BLOOD CELL COUNT INCREASED SEPSIS 4
C WHITE BLOOD CELL COUNT INCREASED THROMBOTIC MICROANGIOPATHY 2
C WHITE BLOOD CELL COUNT INCREASED VIRAL HAEMORRHAGIC CYSTITIS 4
Ads by Google